Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation
US7829708B2 · kind B2 · utility
5Cited by
14References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2005 |
| Grant date | Nov 9, 2010 |
| Priority date | — |
| Expiry date | Mar 4, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for the treatment of disorders of abnormal cell proliferation and/or inflammation, such as psoriasis and inflammatory bowel disease, in a human or other host animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.